Why weight-loss drugs don’t work for some people

Some research suggests between 10% and 30% of GLP-1 drug users may be considered non-responders.

Related

Other articles with overlapping topics.

T

The Conversation

Liver cancer deaths are rapidly increasing – tackling preventable causes would save lives

The major drivers of liver cancer are largely preventable – yet public awareness of the disease remains low.

Dr Nekisa Zakeri, Senior Clinical Lecturer & Consultant Hepatologist, Group Leader Barts Cancer Institute, Queen Mary University of London·Jun 17, 2026

T

The Conversation

How do beta blocker heart drugs actually work for anxiety?

Beta-blockers block the effects of adrenaline, which is released when you’re in fight or flight mode. But they’re best known as a heart drug.

Jasmine Lee, Pharmacist and PhD Candidate, University of Sydney·Jun 17, 2026

Nautilus

Is This the King of GLP-1s?

A new meta-analysis stacks three leading GLP-1 medications against each other The post Is This the King of GLP-1s? appeared first on Nautilus.

Jake Currie·Jun 15, 2026

National Geographic

Why existing vaccines won’t help this Ebola outbreak

As scientists race to develop a new Ebola vaccine to combat the Bundibugyo species, a few leading candidates have emerged.

7 min read

Nautilus

If You’re Counting on Calcium and Vitamin D Supplements to Prevent Fractures, Think Again

A new in-depth analysis casts doubt on the popular supplements The post If You’re Counting on Calcium and Vitamin D Supplements to Prevent Fractures, Think Again appeared first on Nautilus.

Jake Currie·Jun 16, 2026

P

ProPublica

More Than 770,000 Children Are No Longer Receiving SNAP Benefits After Trump Changes Federal Food Program

The post More Than 770,000 Children Are No Longer Receiving SNAP Benefits After Trump Changes Federal Food Program appeared first on ProPublica.

Nicole Santa Cruz·Jun 17, 2026